The Vietnam Viral Hepatitis Alliance (V-VHA) was established in December 2014 in the USA and received its 501(c)3 tax-exempt public charity status in June 2015. In July 2017, V-VHA was granted an international non-government organization (NGO) status by Vietnam’s Department of State.

Our Vision

V-VHA envisions Vietnam being free of viral hepatitis.

Our Mission

The mission of V-VHA is to stimulate and facilitate the design, funding, and collaborative implementation of high-impact public health initiatives in Vietnam to deal decisively with the huge and pressing problems of hepatitis B virus (HBV) and hepatitis C virus (HCV).

Background

Vietnam, with a population of nearly 97 million, has one of the largest viral hepatitis disease burdens in the region and worldwide. In 2017, WHO Vietnam Office and Vietnam Ministry of Health estimated that eight million (8.4%) people in Vietnam are chronic hepatitis B virus (HBV) carriers1. Of the treatment eligible patients with chronic HBV, an estimate of only 1.34% (43,230/3,220,000) is on anti-viral therapy1.

Hepatitis C virus (HCV) is also a serious problem in Vietnam. The overall prevalence of HCV in Vietnam has been estimated to be in the range of 2.2-4.7%2. Similar to the data on HBV treatment, the number of HCV patients who are on HCV therapy is negligible1.

Therapy for HBV or HCV consists of oral nucleoside(tide) analogues or direct acting agent (DAA), respectively, and is available in Vietnam.

Unfortunately, there are millions of individuals chronically infected with HBV or HCV who may eventually develop scaring of the liver and liver cancer.  Most of those who are chronically infected with a hepatitis virus are usually unaware of their infection.

In addition, those who are chronically infected with HBV or HCV are contagious and may inadvertently pass the viral infection on to others; this often includes loved ones.

Clearly, viral hepatitis in Vietnam creates a hugely personal, emotional, social, public health, and economic burden.  Fortunately, in recent years, there have been very good screening tests and pharmaceutical agents that are effective in detecting HBV and HCV for treating infections that may exist.

To address the huge hepatitis problem in Vietnam, bold large-scale programs are needed to provide awareness, information, education, screening, and access to proper medical care.

Established in December 2014, the Vietnam Viral Hepatitis Alliance (V-VHA) is a US-based 501(c)3 nonprofit organization that has been formally recognized in Vietnam as an international non-government organization (NGO) dedicated to discovering, stimulating, and supporting initiatives in eliminating viral hepatitis in Vietnam.

V-VHA recognizes the cooperation and generous support of all who have shared our mission and program goals since we began our journey in 2014.

1Masaya K. “Viral Hepatitis: Global Updates & Implications for Vietnam”. Second Annual Scientific Conference “Joint Action Towards Elimination of Viral Hepatitis in Vietnam: Focus on Special Populations” Conference Center, 272, Vo Thi Sau, District 3, Ho Chi Minh City, Vietnam 2017; Invited Presentation.

2Berto A, Day J, Van Vinh Chau N, et al. Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review. BMC Infect Dis 2017;17:260.

Our Team

Founders & Board of Directors

Doan Y. Dao, M.D.

Doan Y Dao, M.D., is a Founder and President of V-VHA. He is also an Assistant Professor of Medicine, Division of Gastroenterology & Hepatology at Johns Hopkins University School of Medicine. Fluent in English and Vietnamese, Dr. Dao’s personal passion and professional commitment is the study of and care for patients...

Robert R. Gish, M.D.

Robert R. Gish, M.D., FAASLD, is a co-founder and Secretary of V-VHA.  Dr. Gish began his medical training in 1974 when he was enrolled in the Pharmacy School at the University of Kansas. He transferred to the University of Kansas Medical School in 1977 and finished his MD degree in...

Gary Mize, MBA

Gary Mize, MBA, is a co-founder and first Board Chairman of V-VHA. Mr. Mize serves as a Senior Management Advisor to V-VHA.  Mr. Mize has been playing a key role in developing VVHA’s first strategic plan and its first plan for hepatitis screening and access to care in Vietnam. Prior...

William M. Lee, M.D.

William M. Lee, M.D., FACP, FAASLD, is a co-founder and Board member of V-VHA.  Dr. Lee is a renowned liver disease expert and Professor at UT Southwestern. He completed training at Columbia University College of Physicians and Surgeons, Columbia-Presbyterian Medical Center, and Kings College Hospital, London before embarking upon a career in...

Ronald E. McAdams, MBA

Ronald E. McAdams, MBA, is a co-founder and Board member of V-VHA. He has broad business experience, serving since 1979 as President, CEO, or Chairman of a number of companies, both private and public. He has founded over 10 companies, ranging from high technology companies in Silicon Valley to a...

Doan Y Dao V-VHA

Doan Y. Dao, M.D.

Categories: Executive Team, Founders & Board of Directors

Doan Y Dao, M.D., is a Founder and President of V-VHA. He is also an Assistant Professor of Medicine, Division of Gastroenterology & Hepatology at Johns Hopkins University School of Medicine.

Fluent in English and Vietnamese, Dr. Dao’s personal passion and professional commitment is the study of and care for patients with hepatitis B virus (HBV).  He has worked in the HBV field including clinical research, basic science training, patient care, and outreach and advocacy programs for more than 12 years, beginning early in medical school when he took two years off to do HBV translational research. His devotion to HBV in partly stemmed from the large unmet needs in HBV endemic underserved areas of Africa and Asia. He was born and grew up in Vietnam.

Dr. Dao obtained his post-graduate clinical training in Internal Medicine/ Gastroenterology & Hepatology (2012-2019), as part of the Physician Scientist Training Program (PSTP), at UT Southwestern Medical Center, Dallas, Texas. PSTP is a formal mechanism to facilitate and support the development of physician-scientists in academic medicine.

Dr. Dao manages patients with general gastrointestinal diseases or chronic liver diseases. His research focuses on HBV cure. He also dedicates a large portion of his time and efforts to live and work in his native Vietnam towards viral hepatitis elimination.

In addition, Dr. Dao was a past co-Chair of the National Task Force on Hepatitis B: Focus on Asian and Pacific Islander Americans, USA from 2014 – 2018.

In 2010, as a medical student, he established and served as Director (2010-2012) and Advisor (2012-present) of the Dallas Fort Worth (DFW) Hepatitis B Free. Under Dr. Dao’s leadership and support, the DFW Hep B Free has been serving thousands of individuals in the metropolis area and is recognized statewide by Dr. David Lakey, Commissioner of the Texas State Department of Health in 2011 and nationally as a Hep B United Champion in 2015 by Hep B United, a national coalition to address the public health challenge of HBV. In 2016, the Hep B Free was honored by White House for hepatitis awareness efforts.

Supported by a National Institutes of Health (NIH) sponsored T-32 training grant for his basic research in HBV immunobiology, Dr. Dao was also awarded the 2014 Hepatitis Fund for the Cure Postdoctoral Research Fellowship by the American Liver Foundation. In 2016, Dr. Dao was awarded the Asian Heritage Award in Public Health by the Asian Heritage Society, CA, USA. Also in 2016, Dr. Dao was named Everyday Hero by the American Liver Foundation, USA for his effort “tackling hepatitis B from all directions, both in the U.S. and his home country of Vietnam”.

Robert R. Gish V-VHA

Robert R. Gish, M.D.

Categories: Founders & Board of Directors

Robert R. Gish, M.D., FAASLD, is a co-founder and Secretary of V-VHA.  Dr. Gish began his medical training in 1974 when he was enrolled in the Pharmacy School at the University of Kansas. He transferred to the University of Kansas Medical School in 1977 and finished his MD degree in 1980.

Dr. Gish went on to complete a 3-year Internal Medicine residency at the University of California, San Diego and a 4-year Gastroenterology and Hepatology fellowship including transplant medicine at the University of California Los Angeles during which time he was awarded the NIH Physician Scientist Award to study calcium signaling in liver cells.

After completing his training, Dr. Gish moved to San Francisco and took a position at the California Pacific Medical Center (formerly known as Pacific Presbyterian Hospital). He became the Co-Medical Director of the Liver Transplant Program in 1988 and then the Medical Director of the Liver Transplant Program in 1994 until 2010. In that role, he developed an outreach program that eventually served over 35,000 patients in the Northern California and Nevada regions and made the CPMC a leading liver transplant center.

Dr. Gish had and continues to have an active research program in viral hepatitis, liver transplant, bioartificial livers, and public policy especially related to liver cancer, liver transplantation, and viral hepatitis. Although his primary research focus is clinical research, he frequently collaborates with basic scientists in his research activities. He has published more than 600 original articles, review articles, abstracts and book chapters.

Dr. Gish is also actively involved in numerous professional societies and is a long-term member of the American Association for the Study of Liver Disease, European Association for the Study of Liver Disease, Asian Pacific Association for the Study of the Liver, and the American Society of Transplantation.

He is a fellow of both the American College of Physicians and the American Association for the Study of Liver Disease. Dr. Gish has served on the editorial boards of American Journal of Gastroenterology, Journal of Hepatology, Digestive Diseases and Sciences, Gastroenterology, Hepatology, Liver Transplantation and Surgery, and Journal of Viral Hepatitis among many others. He has co-authored a public health policy for liver health in Vietnam and is also assisting with the development of healthcare policies in Armenia and the Philippines.

In December 2010, Dr. Gish moved to San Diego to join the faculty of UCSD as a Clinical Professor of Medicine, Section Chief of Hepatology, and Director of the Center of Excellence for Hepatobiliary Disease and Abdominal Transplantation (C.H.A.T.).

In September of 2013, Dr. Gish left UCSD to form a consulting company, Robert G. Gish Consultants LLC to provide consultative support to Hepatology Centers and Liver Transplant Programs who wish to start or grow their programs through pathways of quality and optimal patient care that is integrated with research and education.

At that time, Dr. Gish joined Dr. Manch at St Joseph’s Hospital and Medical Center to start a liver transplant center and worked to establish a UNOS and Medicare certified program in 2016. Between April 2014 and June 2019, Dr. Gish served at Stanford’s Department of Medicine, Division of Gastroenterology and Hepatology and Liver Transplant Service Line as a Staff Physician with major roles with in-reach and outreach as well as program development.

Over the years of 2012 to current, Dr. Gish has been and continues to be very active with the National Viral Hepatitis Round Table (NVHR) a patient and community advocacy non-profit organization. In February of 2014, Dr. Gish joined the Hepatitis B Foundation, (HBF) as their Medical Director to lend his policy, advocacy and clinical science skills to their armamentarium.

Today, Dr. Gish is an Adjunct Professor of Medicine at the University of Nevada School of Medicine in Las Vegas, a Clinical Professor at the University of Nevada Reno School of Medicine, and a Clinical Professor at the University of California Skaggs School of Pharmacy and Pharmaceutical Sciences. In addition, he is also the Medical Director of the Hepatitis B Foundation and Medical Director of the Asian Pacific Health Foundation. Dr. Gish has joined the consulting faculty at La Maestra in San Diego to establish a liver care program in the Federally Qualified Health Care clinic.

Gary Mize V-VHA

Gary Mize, MBA

Categories: Founders & Board of Directors

Gary Mize, MBA, is a co-founder and first Board Chairman of V-VHA. Mr. Mize serves as a Senior Management Advisor to V-VHA.  Mr. Mize has been playing a key role in developing VVHA’s first strategic plan and its first plan for hepatitis screening and access to care in Vietnam.

Prior to his retirement, Mr. Mize was a Vice President at Bristol-Myers Squibb (BMS) where he was in charge of Worldwide Strategic Product Planning for the cardiovascular area. Prior to that, he was Vice President of Marketing in the Bristol-Myers U.S. Pharmaceutical Division. Mr. Mize’s career at BMS spanned over 20 years following his service in the Army Medical Service Corps where he achieved the rank of Captain while working as Chief of the Management Services Division for a 150-bed Army hospital.

After retiring from Bristol-Myers Squibb, Mr. Mize became a management consultant and advisor to BMS, DuPont-Merck Pharmaceutical Company, Mead Johnson Nutritionals, Bristol-Myers Squibb – China, and the Center for Applied Value Analysis – a company founded to develop value analytics solutions in the health care area.

Mr. Mize received his BS in General Management from Indiana University and his MBA from the Indiana University Graduate School of Business.

William M. Lee V-VHA

William M. Lee, M.D.

Categories: Founders & Board of Directors

William M. Lee, M.D., FACP, FAASLD, is a co-founder and Board member of V-VHA.  Dr. Lee is a renowned liver disease expert and Professor at UT Southwestern. He completed training at Columbia University College of Physicians and Surgeons, Columbia-Presbyterian Medical Center, and Kings College Hospital, London before embarking upon a career in academic medicine. He joined the UT Southwestern Medical Center faculty in 1990. Dr. Lee’s clinical research and patient care has focused on all forms of hepatitis—causes of inflammation and damage to the liver.

Dr. Lee became a hepatologist because the diseases of the liver are fascinating and represent unusual and important lessons in medicine.

After completing his medical degree from Columbia University College of Physicians and Surgeons, Dr. Lee completed his residency in Internal Medicine at Presbyterian Hospital, New York City, where he also served as Chief Resident. He then went on to serve as Honorary Registrar and Research Fellow to Dr. Roger Williams at the Liver Unit, Kings College Hospital, London from 1973-74. Dr. Lee joined the UT Southwestern faculty after more than two decades of experience as both a clinician and researcher.

Dr. Lee remains active in clinical research on viral hepatitis and drug-induced liver injury. He has been site investigator for four National Institute of Diabetes, Digestive and Kidney Diseases-sponsored Networks: the HALT-C Trial, the Acute Liver Failure Study Group, the Drug-Induced Liver Injury Network, and the Hepatitis B Research Network.

Dr. Lee says he chose UT Southwestern because it has tremendous research depths in the basic and clinical sciences.

He is a member of the American Association for the Study of Liver Diseases (AASLD) and the American Gastroenterological Association, and is a Fellow of the American College of Physicians and the American College of Gastroenterology. In 2009, he gave the prestigious Leon Schiff Memorial Lecture at the Annual AASLD meeting and in 2011 he received the Award for Excellence for Outstanding Contributions in Health/Sciences from the Dallas Historical Society. During the past year, he has given numerous lectures on topics related to his research.

Dr. Lee obtained his B.A. from Amherst College and received his medical degree from Columbia University College of Physicians and Surgeons. He did his training in Internal Medicine at the Presbyterian Hospital, New York City (Columbia-Presbyterian Medical Center) and served as Chief Resident on the Internal Medicine service. He was Honorary Registrar and Research Fellow to Dr. Roger Williams at the Liver Unit, Kings College Hospital, London from 1973-74. He has been on the faculty of Columbia University College of Physicians and Surgeons, and was Director of the Gastroenterology Division at the Medical University of South Carolina before coming to UT Southwestern in 1990.

Ronald E. McAdams V-VHA

Ronald E. McAdams, MBA

Categories: Founders & Board of Directors

Ronald E. McAdams, MBA, is a co-founder and Board member of V-VHA. He has broad business experience, serving since 1979 as President, CEO, or Chairman of a number of companies, both private and public. He has founded over 10 companies, ranging from high technology companies in Silicon Valley to a natural meat company in Billings, MT.

In his early career Mr. McAdams worked in corporate finance for two Fortune 500 companies in the energy and chemical markets, ending as Treasurer of Raychem, Inc. in 1979. He started his first company after leaving Raychem, resulting in an IPO in 1984. This company and a number of other companies he founded were in the medical technology field, an area where he has extensive experience. In 1986 he became Chairman and CEO of a public medical company, leading a turn-around that advanced the stock price from $1.50 to $21.50 before resigning to move to Montana in 1991. Soon after that he bought a company that he relocated to Montana. He sold that company in 2006.

Mr. McAdams has also taught Entrepreneurship and Strategic Management at the university level, including being Executive Entrepreneur in Residence at Montana State University for four years. Mr. McAdams has a BS from the University of Evansville and an MBA in Finance from the Wharton School, where he was a Joseph Wharton Fellow. Prior to receiving his degrees he was in the military, working first at several Naval Hospitals before being assigned to Alpha Company, 1stBattalion1stMarines, in Vietnam, as a medical corpsman with the USMC. In summer of 1966 he attended the Intensive Vietnamese Language Program in Danang, Vietnam. And, in January 1967 he received the Purple Heart and the Bronze Star with Combat “V” for Valor.

 

Executive Team

Doan Y. Dao, M.D.

Doan Y Dao, M.D., is a Founder and President of V-VHA. He is also an Assistant Professor of Medicine, Division of Gastroenterology & Hepatology at Johns Hopkins University School of Medicine. Fluent in English and Vietnamese, Dr. Dao’s personal passion and professional commitment is the study of and care for patients...

Lily Trang Pham, M.D.

Lily Trang Pham, M.D., Vice-President of Professional Relations & Program Management. Dr. Lily Trang Ngoc Doan Pham, M.D. is Vice President of Professional Relations and Program Management for V-VHA. She served as the Program Manager for V-VHA’s Cornerstone program in Vietnam. Dr. Pham is currently a PhD candidate in Public Health...

Amy Trang, Ph.D., M.Ed.

Amy Trang, Ph.D., M.Ed., Vice-President of Administrative Services & Planning.  Dr. Amy Trang, PhD, MEd is Vice-President of Administrative Services and Planning for V-VHA.  She is also the founder and CEO of Social Capital Solutions, Inc. Since 2014, Dr. Trang has served as the Administrator for the National Task Force...

Anh Le, Ph.D.

Anh Le, Ph.D., Chief Technology Officer.  Dr. Anh Le, Ph.D. is the Chief Technology Officer for V-VHA and Director for the Information Center at Saigon University, Ho Chi Minh City (HCMC), Vietnam. Before that, he was CEO of MyXTeam and Vice Director of the Research & Development Department as well as...

Doan Y Dao V-VHA

Doan Y. Dao, M.D.

Categories: Executive Team, Founders & Board of Directors

Doan Y Dao, M.D., is a Founder and President of V-VHA. He is also an Assistant Professor of Medicine, Division of Gastroenterology & Hepatology at Johns Hopkins University School of Medicine.

Fluent in English and Vietnamese, Dr. Dao’s personal passion and professional commitment is the study of and care for patients with hepatitis B virus (HBV).  He has worked in the HBV field including clinical research, basic science training, patient care, and outreach and advocacy programs for more than 12 years, beginning early in medical school when he took two years off to do HBV translational research. His devotion to HBV in partly stemmed from the large unmet needs in HBV endemic underserved areas of Africa and Asia. He was born and grew up in Vietnam.

Dr. Dao obtained his post-graduate clinical training in Internal Medicine/ Gastroenterology & Hepatology (2012-2019), as part of the Physician Scientist Training Program (PSTP), at UT Southwestern Medical Center, Dallas, Texas. PSTP is a formal mechanism to facilitate and support the development of physician-scientists in academic medicine.

Dr. Dao manages patients with general gastrointestinal diseases or chronic liver diseases. His research focuses on HBV cure. He also dedicates a large portion of his time and efforts to live and work in his native Vietnam towards viral hepatitis elimination.

In addition, Dr. Dao was a past co-Chair of the National Task Force on Hepatitis B: Focus on Asian and Pacific Islander Americans, USA from 2014 – 2018.

In 2010, as a medical student, he established and served as Director (2010-2012) and Advisor (2012-present) of the Dallas Fort Worth (DFW) Hepatitis B Free. Under Dr. Dao’s leadership and support, the DFW Hep B Free has been serving thousands of individuals in the metropolis area and is recognized statewide by Dr. David Lakey, Commissioner of the Texas State Department of Health in 2011 and nationally as a Hep B United Champion in 2015 by Hep B United, a national coalition to address the public health challenge of HBV. In 2016, the Hep B Free was honored by White House for hepatitis awareness efforts.

Supported by a National Institutes of Health (NIH) sponsored T-32 training grant for his basic research in HBV immunobiology, Dr. Dao was also awarded the 2014 Hepatitis Fund for the Cure Postdoctoral Research Fellowship by the American Liver Foundation. In 2016, Dr. Dao was awarded the Asian Heritage Award in Public Health by the Asian Heritage Society, CA, USA. Also in 2016, Dr. Dao was named Everyday Hero by the American Liver Foundation, USA for his effort “tackling hepatitis B from all directions, both in the U.S. and his home country of Vietnam”.

Lily Trang Pham V-VHA

Lily Trang Pham, M.D.

Categories: Executive Team

Lily Trang Pham, M.D., Vice-President of Professional Relations & Program Management. Dr. Lily Trang Ngoc Doan Pham, M.D. is Vice President of Professional Relations and Program Management for V-VHA. She served as the Program Manager for V-VHA’s Cornerstone program in Vietnam. Dr. Pham is currently a PhD candidate in Public Health at the University of Illinois at Chicago (UIC), where she works as Research Assistant in an evaluation project for the Illinois Breast and Cervical Cancer program, and Data Analyst for the Healthy Pregnancy study. She received her MS degree in Epidemiology at UIC under the Vietnam Education Foundation (VEF) fellowship.

Dr. Pham received her MD from the Pham Ngoc Thach University of Medicine in 2005 and Obstetrics and Gynecology specialty training from the University of Medicine and Pharmacy at Ho Chi Minh City from 2006- 2008. She was a Hoc Mai Foundation alumna, cohort 2008. Dr. Pham gained experience in international collaborative work with not-for-profit organizations from projects at the Department of Scientific Research and International Collaboration at Pham Ngoc Thach University of Medicine. Dr. Pham’s research interests are in infectious diseases, maternal child health, health intervention evaluation, and database management system.

Amy Trang V-VHA

Amy Trang, Ph.D., M.Ed.

Categories: Executive Team

Amy Trang, Ph.D., M.Ed., Vice-President of Administrative Services & Planning.  Dr. Amy Trang, PhD, MEd is Vice-President of Administrative Services and Planning for V-VHA.  She is also the founder and CEO of Social Capital Solutions, Inc. Since 2014, Dr. Trang has served as the Administrator for the National Task Force on Hepatitis B Focus on Asian and Pacific Islander Americans. As the Administrator for the Task Force, Dr. Trang has worked alongside physicians and public health researchers to develop education curriculum on hepatitis B and C for liver cancer prevention as well as training seminars (in-person and virtually) targeted at primary care providers and mid-level practitioners.

Dr. Trang is passionate about raising awareness about viral hepatitis screening and linkages to care services because she has family and friends personally affected by it. In addition to the National Task Force on Hepatitis B Focus on Asian and Pacific Islander Americans, she also serves as a Program Development Consultant for HBI-DC; she has assisted those nonprofit organizations with developing culturally and linguistically appropriate patient education curriculum and learning materials. She has also been serving on the Hep B United National Advisory Committee since 2017.

Dr. Trang completed her doctorate degree in Public Policy from George Mason University School of Public Policy after transferring her doctoral studies in Culture and Values of Education from McGill University (Montreal, Canada). She holds a master’s degree in Social and Psychological Foundations of Education from the University of Virginia (UVA) School of Education and Human Development, and a bachelor’s degree in International Studies from George Mason University. She has also been an adjunct faculty at UVA since 2000, where she has taught Sociology of Education, Education in Multicultural Societies, Anthropology of Education, Critical Education Policy, Comparative Education, and Asian Education. She was one of the first faculty at UVA to successfully pilot an online course in 2015.

Anh Le, Ph.D.

Categories: Executive Team

Anh Le, Ph.D., Chief Technology Officer.  Dr. Anh Le, Ph.D. is the Chief Technology Officer for V-VHA and Director for the Information Center at Saigon University, Ho Chi Minh City (HCMC), Vietnam. Before that, he was CEO of MyXTeam and Vice Director of the Research & Development Department as well as Senior Software Developer, Personify, Inc.

Dr. Le earned his B.S. degree from HCMC University of Technology, HCMC, Vietnam and Ph.D. from University of New York at Buffalo, NY, USA. He joined the Coordinated Science Laboratory at the University of Illinois at Urbana-Champaign, IL, USA as a post-doctoral research fellow in 2010.

Dr. Le has received several awards including the Vietnam Education Foundation Fellowship in 2003 and HCMC People’s Committee Graduate Fellowship.

 

Our Alliances

Alliance Memberships

Our Collaborators

  • Ho Chi Minh City Health Department
  • Ho Chi Minh City Open University
  • Medic Medical Center
  • Pham Ngoc Thach University School of Medicine
  • U.S. Centers for Disease Control and Prevention (CDC) Vietnam Office
  • Vietnam Red Cross Society
  • Vietnam Ministry of Health
  • World Health Organization Western Pacific Region
  • World Health Organization Vietnam Office

Our Partners & Sponsors

Support Our Work

V-VHA is grateful for the support that we have received in the past from generous donations and research grants. Funds received help maintain our operations in Vietnam, especially the outreach, education, free screening / testing, and linkage to care services that our staff provides to individuals in the community, many of whom are living with chronic hepatitis B or hepatitis C and are trying to prevent liver cancer. Since beginning our work in Vietnam in 2015, we have screened and tested over 20,000 individuals living in Ho Chi Minh City and identified nearly 10% of the screened population as having been infected with HBV and/or HCV.

Please continue to support our efforts in addressing this infectious disease burden in Vietnam so that we could help eliminate viral hepatitis in the country by 2030. We welcome philanthropic donations and research grants, as well as students who are interested in doing graduate level medical research.

Support Our Work!

Scroll to Top